Study of anti-apolipoprotein A-I antibodies and paraoxonase 1 activity in systemic lupus erythematosus patients; correlation with disease activity and damage indices / Iman Mohamed Fikry Ragai ; Supervised Eman Mahmoud Elserougy , Mohammed Mahmoud Ahmed , Dawoud Fakhry Habib

By:

Iman Mohamed Fikry Ragai

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Iman Mohamed Fikry Ragai , 2012Description: 185 P. : charts , facsimiles ; 25cmOther title:

دراسة الأجسام المضادة للأبوليبوبروتين أ-1 و نشاط الباراأوكسونيزا فى مرضى الذئبة الحمراء و علاقتهم بمؤشرات النشاط و التلف للمرض [Added title page title]

Subject(s):

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilitation Summary: Systemic lupus erythematosus (SLE) patients have an increased risk of atherosclerosis. Identification of at-risk patients and the pathogenesis of atherosclerosis in SLE remain elusive. Paraoxonase 1 (PONI) and anti-apolipoprotein A-1 antibody (anti-Apo A-1) appear to have a potential role in premature atherosclerosis in SLE

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Date due	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.32.Ph.D.2012.Im.S (Browse shelf(Opens below))		Not for loan		01010110060076000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.32.Ph.D.2012.Im.S (Browse shelf(Opens below))	60076.CD	Not for loan		01020110060076000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.11.32.Ph.D.2012.Ha.N New advances in the management of ankylosing spondylitis : Anti tumor necrosis factor Ü targeted therapy /	Cai01.11.32.Ph.D.2012.Ha.N New advances in the management of ankylosing spondylitis : Anti tumor necrosis factor Ü targeted therapy /	Cai01.11.32.Ph.D.2012.Im.S Study of anti-apolipoprotein A-I antibodies and paraoxonase 1 activity in systemic lupus erythematosus patients; correlation with disease activity and damage indices /	Cai01.11.32.Ph.D.2012.Im.S Study of anti-apolipoprotein A-I antibodies and paraoxonase 1 activity in systemic lupus erythematosus patients; correlation with disease activity and damage indices /	Cai01.11.32.Ph.D.2012.Ma.A Adrenomedullin-a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus /	Cai01.11.32.Ph.D.2012.Ma.A Adrenomedullin-a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus /	Cai01.11.32.Ph.D.2012.Ma.U Urinary tweak; a biomarker for lupus nephritis activity /	Next

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilitation

Systemic lupus erythematosus (SLE) patients have an increased risk of atherosclerosis. Identification of at-risk patients and the pathogenesis of atherosclerosis in SLE remain elusive. Paraoxonase 1 (PONI) and anti-apolipoprotein A-1 antibody (anti-Apo A-1) appear to have a potential role in premature atherosclerosis in SLE

Issued also as CD

There are no comments on this title.

to post a comment.